Lv63
2740 积分 2023-11-13 加入
Proteome-wide multicenter mendelian randomization analysis to identify novel therapeutic targets for lung cancer
8天前
已完结
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non–Small-Cell Lung Cancer
1个月前
已完结
“New Targets in Non-Small-Cell Lung Cancer” - RET, HER2 and KRAS
3个月前
已完结
Clinicopathologic and Molecular Characteristics of HER2 (ERBB2)-Altered Non-Small Cell Lung Cancer: Implications for Precision Medicine
3个月前
已完结
Quantitative Measurement of HER2 Expression in Non-Small Cell Lung Cancer with a High Sensitivity Assay
3个月前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
3个月前
已完结
CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer
3个月前
已完结
Large-scale integration of the plasma proteome with genetics and disease
6个月前
已完结
Lung cancer screening
11个月前
已完结
Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers
11个月前
已完结
皖公网安备34019202002308
